Indian government has extended price caps to 39 more medicines ranging from commonly used diabetes drugs to antibiotics.
Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients
Nestle now has less than two weeks to convince the regulator why product approval for its noodles should not be withdrawn
Nestle is confident of getting back Maggi on India shelves.
As Modi completes a year in office, his cuts in federal welfare spending on the poorest of India's 1.25 bn people are coming in for sharp criticism.
Few drugs in the market are not approved by the authorities and can be life-threatening.
Up to 900,000 Indians die every year of tobacco-related diseases
GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.
Uber and Ola continued to operate in New Delhi while their licence applications were pending approval.
Prime Minister Narendra Modi signalled on Monday he would not bow to foreign pressure to commit to cuts in carbon emissions.
The decision to slash insurance coverage will have an impact on private health sector.
Sun Pharma open to large acquisitions post Ranbaxy.
India had ordered all unregistered web-based taxi cos to halt operations
Modi's government is also working on a universal health coverage plan that would provide all citizens with free drugs and diagnostic treatment.
US taxi-hailing app maker Uber Technologies Inc has restarted services in India's capital, after its three apps were banned following allegations of rape
The United Nations estimates about one third of the world's 1.2 billion poorest people live in India
Novartis said it is partnered with generic drugmaker Lupin Ltd to sell the drug in India
The new drugs to come under price control include commonly-used antibiotics and painkillers
India's antitrust regulator has approved Sun-Ranbaxy deal, subject to the companies divesting seven products.
Shares in ITC Ltd , India's largest cigarette maker, closed 5.2 per cent lower in a broader Mumbai market that fell 0.8 percent.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances